Decompression of the left heart chambers via atrial flow regulator: A new insight into heart failure treatment

References (1)

1. Rajeshkumar R, Pavithran S, Sivakumar K, Vettukattil JJ. Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension. Catheter Cardiovasc Interv 2017; 90: 1145-53. [Crossref] 2. Dąbrowska-Kugacka A, Ciećwierz D, Żuk G, Fijałkowski M, Ottowicz A, Kwiatkowska J, et al. Atrial flow regulator for severe drug resistant pulmonary arterial hypertension after congenital heart defect correction. Cardiol J 2019; 26: 102-4. [Crossref] 3. Paitazoglou C, Özdemir R, Pfister R, Bergmann MW, Bartunek J, Kilic T, et al. The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction. EuroIntervention 2019; 15: 403-10. [Crossref] 4. Guimarães L, Del Val D, Rodés-Cabau J. The Atrial Flow Regulator device: expanding the field of interatrial shunting for treating heart failure patients. EuroIntervention 2019; 15: 398-400. [Crossref]